275 related articles for article (PubMed ID: 11549418)
1. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
[TBL] [Abstract][Full Text] [Related]
2. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection.
Zunino P; Geymonat L; Allen AG; Legnani-Fajardo C; Maskell DJ
FEMS Immunol Med Microbiol; 2000 Oct; 29(2):137-43. PubMed ID: 11024353
[TBL] [Abstract][Full Text] [Related]
3. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
[TBL] [Abstract][Full Text] [Related]
5. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
Li X; Johnson DE; Mobley HL
Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
[TBL] [Abstract][Full Text] [Related]
6. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
[TBL] [Abstract][Full Text] [Related]
7. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
[TBL] [Abstract][Full Text] [Related]
8. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection.
Massad G; Lockatell CV; Johnson DE; Mobley HL
Infect Immun; 1994 Feb; 62(2):536-42. PubMed ID: 7905463
[TBL] [Abstract][Full Text] [Related]
9. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
[No Abstract] [Full Text] [Related]
10. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
[TBL] [Abstract][Full Text] [Related]
11. Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins.
Scavone P; Sosa V; Pellegrino R; Galvalisi U; Zunino P
Microbes Infect; 2004 Jul; 6(9):853-60. PubMed ID: 15374007
[TBL] [Abstract][Full Text] [Related]
12. Fimbriae of uropathogenic Proteus mirabilis.
Rocha SP; Pelayo JS; Elias WP
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
[TBL] [Abstract][Full Text] [Related]
13. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis.
Li X; Lockatell CV; Johnson DE; Mobley HL
Mol Microbiol; 2002 Aug; 45(3):865-74. PubMed ID: 12139630
[TBL] [Abstract][Full Text] [Related]
14. New aspects of RpoE in uropathogenic Proteus mirabilis.
Liu MC; Kuo KT; Chien HF; Tsai YL; Liaw SJ
Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796
[TBL] [Abstract][Full Text] [Related]
15. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
[TBL] [Abstract][Full Text] [Related]
16. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.
Jansen AM; Lockatell V; Johnson DE; Mobley HL
Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655
[TBL] [Abstract][Full Text] [Related]
17. Repression of bacterial motility by a novel fimbrial gene product.
Li X; Rasko DA; Lockatell CV; Johnson DE; Mobley HL
EMBO J; 2001 Sep; 20(17):4854-62. PubMed ID: 11532949
[TBL] [Abstract][Full Text] [Related]
18. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
Zunino P; Piccini C; Legnani-Fajardo C
Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
[TBL] [Abstract][Full Text] [Related]
19. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
[TBL] [Abstract][Full Text] [Related]
20. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.
Zhao H; Li X; Johnson DE; Mobley HLT
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
